Vai trò của CCR2 trong miễn dịch học và sinh học thần kinh

10.1038/29788

10.1172/JCI200420126

10.2337/db08-0625

10.1517/13543784.2011.575359

10.1056/NEJMra052723

10.1016/j.it.2006.11.004

10.1189/jlb.1107763

10.1016/j.tips.2005.11.002

10.1016/j.immuni.2009.09.010

Fraser CM, 1989, Site‐directed mutagenesis of m1 muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function, Mol Pharmacol, 36, 840

10.1073/pnas.91.7.2752

Murphy PM, 2000, International union of pharmacology. XXII. Nomenclature for chemokine receptors, Pharmacol Rev, 52, 145

10.1074/jbc.272.2.1038

10.1074/jbc.271.13.7551

10.1074/jbc.271.20.11603

10.1016/S0165-5728(98)00005-8

10.1016/j.ceb.2004.01.001

10.1074/jbc.271.32.19084

10.1074/jbc.272.37.23186

10.1161/01.ATV.19.9.2085

Hogaboam CM, 1999, Differential monocyte chemoattractant protein‐1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1‐ and Th2‐type pulmonary granuloma models, J Immunol, 163, 2193, 10.4049/jimmunol.163.4.2193

10.1371/journal.pone.0013693

10.1182/blood.V94.3.875.415k28_875_883

10.1016/S1074-7613(03)00174-2

10.1189/jlb.0407247

10.1097/MOH.0b013e3283324f80

10.1074/jbc.272.18.11682

10.1074/jbc.270.38.22123

10.4049/jimmunol.157.12.5613

10.1093/intimm/13.8.1021

10.1084/jem.185.1.99

10.1016/S0076-6879(09)05409-3

10.1146/annurev.immunol.22.012703.104543

10.1007/s10540-006-9025-9

10.1074/jbc.M311224200

10.1016/S0092-8674(00)81364-1

10.1182/blood.V90.3.909

10.1517/14728222.7.1.35

10.1038/ni1222

10.1016/j.stem.2008.03.003

10.4049/jimmunol.0803469

10.1002/jlb.62.1.30

Polentarutti N, 1997, IL‐2‐regulated expression of the monocyte chemotactic protein‐1 receptor (CCR2) in human NK cells: characterization of a predominant 3.4‐kilobase transcript containing CCR2B and CCR2A sequences, J Immunol, 158, 2689, 10.4049/jimmunol.158.6.2689

10.1084/jem.184.2.569

Perera LP, 1999, IL‐15 induces the expression of chemokines and their receptors in T lymphocytes, J Immunol, 162, 2606, 10.4049/jimmunol.162.5.2606

10.1161/01.ATV.18.12.1983

10.1084/jem.185.5.969

10.1002/jlb.65.2.265

10.1073/pnas.97.6.2761

10.1016/S0021-9150(99)00021-0

10.1074/jbc.272.12.8050

Penton‐Rol G, 1998, Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN‐gamma, J Immunol, 160, 3869, 10.4049/jimmunol.160.8.3869

10.4049/jimmunol.162.1.474

Franci C, 1996, Phosphorylation by a G protein‐coupled kinase inhibits signaling and promotes internalization of the monocyte chemoattractant protein‐1 receptor. Critical role of carboxyl‐tail serines/threonines in receptor function, J Immunol, 157, 5606, 10.4049/jimmunol.157.12.5606

10.1016/S0301-0082(01)00023-5

10.1016/j.cellsig.2009.07.010

10.1084/jem.194.9.1361

10.1172/JCI119798

10.1038/ni1309

10.1172/JCI29919

10.1016/j.immuni.2008.05.019

10.1084/jem.187.4.601

10.1016/S1097-2765(00)80139-2

10.1161/01.CIR.103.16.2096

10.1189/jlb.0903421

10.1096/fj.10-171579

10.1038/nm.1945

Frazier‐Jessen MR, 1995, Estrogen modulation of JE/monocyte chemoattractant protein‐1 mRNA expression in murine macrophages, J Immunol, 154, 1838, 10.4049/jimmunol.154.4.1838

10.1182/blood-2007-10-118497

10.1038/nature09615

10.1126/science.1194637

10.1128/MCB.20.11.4106-4114.2000

10.1016/S1044-5323(02)00125-2

10.1016/S0002-9440(10)65249-2

10.1016/S0165-5728(98)00002-2

10.4049/jimmunol.155.12.5769

10.1172/JCI5150

10.1046/j.1468-1331.2001.00327.x

Mahad DJ, 2002, Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis, J Neurol Neurosurg Psychiatry, 72, 498

Franciotta D, 2002, Caspase‐1 levels in biological fluids from patients with multiple sclerosis and from patients with other neurological and non‐neurological diseases, Eur Cytokine Netw, 13, 99

10.1016/S0022-510X(01)00680-3

10.1034/j.1600-0404.2001.104002088.x

10.1007/BF00684996

10.1084/jem.192.7.1075

10.1016/j.it.2008.01.010

10.1016/S0002-9440(10)63805-9

10.1111/j.1755-3768.2010.01953.x

10.1084/jem.192.6.899

10.1084/jem.193.6.713

10.1126/science.287.5453.602

10.1073/pnas.202357499

10.1086/323478

10.1096/fasebj.7.6.8472896

10.1016/j.tips.2008.08.004

10.1016/j.jneuroim.2006.11.017

10.1016/j.neurobiolaging.2003.12.026

10.1038/nm1555

10.1172/JCI31450

10.1038/nn.2432

10.1073/pnas.0805453106

10.1073/pnas.1331358100

10.1016/j.neuroscience.2007.08.014

10.1016/j.neures.2004.01.004

10.1111/j.1471-4159.2007.04969.x

10.1097/ACO.0b013e32830eb69d

10.1073/pnas.0503496102

10.1523/JNEUROSCI.5986-10.2011

10.1124/mol.108.053470

10.1038/nrd2734

10.1161/ATVBAHA.108.168633

10.1517/13543770902755129

10.1038/jcbfm.2009.240

Franci C, 1995, Monocyte chemoattractant protein‐3, but not monocyte chemoattractant protein‐2, is a functional ligand of the human monocyte chemoattractant protein‐1 receptor, J Immunol, 154, 6511, 10.4049/jimmunol.154.12.6511

10.1002/jlb.62.6.911

10.1002/jlb.61.3.353